- Report
- July 2022
- 255 Pages
Global
From €4247EUR$4,450USD£3,558GBP
- Report
- February 2024
- 30 Pages
Global
From €3102EUR$3,250USD£2,599GBP
- Clinical Trials
- January 2024
- 100 Pages
Global
From €1909EUR$2,000USD£1,599GBP
- Report
- August 2022
- 120 Pages
Global
From €4295EUR$4,500USD£3,598GBP
- Report
- October 2022
- 138 Pages
Global
From €4247EUR$4,450USD£3,558GBP
- Report
- February 2023
- 107 Pages
Global
From €7158EUR$7,500USD£5,997GBP
- Report
- January 2024
- 189 Pages
Global
From €7158EUR$7,500USD£5,997GBP
- Drug Pipelines
- January 2024
- 60 Pages
Global
From €1432EUR$1,500USD£1,199GBP
- Clinical Trials
- January 2024
- 60 Pages
Global
From €1432EUR$1,500USD£1,199GBP
- Clinical Trials
- January 2024
- 60 Pages
Global
From €1193EUR$1,250USD£1,000GBP
- Clinical Trials
- January 2024
- 60 Pages
Global
From €1193EUR$1,250USD£1,000GBP
- Report
- November 2023
- 30 Pages
Global
From €2625EUR$2,750USD£2,199GBP
- Report
- November 2023
- 30 Pages
Global
From €2625EUR$2,750USD£2,199GBP
- Report
- November 2023
- 30 Pages
Global
From €2625EUR$2,750USD£2,199GBP
- Report
- August 2023
- 201 Pages
Global
From €7158EUR$7,500USD£5,997GBP
- Report
- February 2023
- 50 Pages
Global
From €3770EUR$3,950USD£3,159GBP
- Report
- January 2022
- 90 Pages
Global
From €1909EUR$2,000USD£1,599GBP
- Report
- January 2022
- 70 Pages
Global
From €954EUR$1,000USD£800GBP
- Report
- February 2024
- 70 Pages
United States
From €4533EUR$4,750USD£3,798GBP
- Report
- February 2024
- 70 Pages
China
From €4533EUR$4,750USD£3,798GBP

The insulin market is a subset of the larger endocrine and metabolic disorders drugs market. Insulin is a hormone produced by the pancreas that helps regulate the body's blood sugar levels. It is used to treat diabetes, a condition in which the body does not produce enough insulin or is unable to use it effectively. Insulin is available in both short-acting and long-acting forms, and is typically administered via injection or an insulin pump.
The insulin market is highly competitive, with a number of major pharmaceutical companies offering a variety of insulin products. These include Eli Lilly, Novo Nordisk, Sanofi, and Merck. Additionally, there are a number of smaller companies that specialize in the production of insulin, such as Biocon, Wockhardt, and Wockhardt USA. Show Less Read more